Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCRL | Q16602 | 6/20 | 0.51 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.48 |
| ▸ | BACE1 | P56817 | 4/20 | 0.47 |
| ▸ | CTSD | P07339 | 3/20 | 0.47 |
| ▸ | XIAP | P98170 | 1/20 | 0.42 |
| ▸ | STAT3 | P40763 | 1/20 | 0.42 |
| ▸ | RAMP1 | O60894 | 1/20 | 0.42 |
| ▸ | CMA1 | P23946 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29733250 | 0.91 | CALCRL (0.47) | CALCRLSLC6A2BACE1CTSDXIAP | |
| SCHEMBL31031582 | 0.90 | XIAP (0.48) | CALCRLSLC6A2XIAPSTAT3 | |
| SCHEMBL29641778 | 0.88 | XIAP (0.47) | CALCRLSLC6A2XIAPSTAT3CMA1 | |
| SCHEMBL29968168 | 0.86 | CALCRL (0.54) | CALCRLSLC6A2BACE1CTSDRAMP1 | |
| SCHEMBL7401470 | 0.86 | CALCRL (0.48) | CALCRLSLC6A2BACE1CTSDSTAT3 | |
| SCHEMBL31182552 | 0.85 | BACE1 (0.47) | CALCRLSLC6A2BACE1CTSDSTAT3 | |
| SCHEMBL30495673 | 0.85 | BACE1 (0.49) | CALCRLBACE1CTSD | |
| SCHEMBL30386802 | 0.85 | NTSR2 (0.49) | CALCRLBACE1CTSD | |
| SCHEMBL29630819 | 0.85 | XIAP (0.47) | CALCRLSLC6A2BACE1CTSDXIAP | |
| SCHEMBL29641790 | 0.84 | GRB2 (0.49) | CALCRLSLC6A2BACE1CTSDCMA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260071227-A1 | METHOD FOR SECRETORY PRODUCTION OF PROTEINS | AJINOMOTO CO., INC. (JP) | 2026-03-12 | — | — | US | disclosed |
| EP-4667580-A1 | METHOD FOR SECRETORY PRODUCTION OF PROTEINS | AJINOMOTO CO., INC. (JP) | 2025-12-24 | — | — | EP | disclosed |
| EP-4509613-A1 | METHOD FOR PRODUCING CULTURED MEAT | AJINOMOTO CO., INC. (JP) | 2025-02-19 | — | — | EP | disclosed |
| US-20250026799-A1 | METHOD FOR PRODUCING CULTURED MEAT | AJINOMOTO CO., INC. (JP) | 2025-01-23 | — | — | US | disclosed |
| CN-119053709-A | Method for producing cultured meat | 味之素株式会社 | 2024-11-29 | — | — | CN | disclosed |
| WO-2024172163-A1 | METHOD FOR SECRETORY PRODUCTION OF PROTEINS | 味の素株式会社 | 2024-08-22 | — | — | WO | disclosed |
| US-20240209409-A1 | Method for Secretory Production of Unnatural-Amino-Acid-Containing Protein | AJINOMOTO CO., INC. (JP) | 2024-06-27 | — | — | US | disclosed |
| EP-4368722-A1 | METHOD FOR SECRETORY PRODUCTION OF UNNATURAL-AMINO-ACID-CONTAINING PROTEIN | AJINOMOTO CO., INC. (JP) | 2024-05-15 | — | — | EP | disclosed |
| WO-2023200008-A1 | METHOD FOR PRODUCING CULTURED MEAT | 味の素株式会社 | 2023-10-19 | — | — | WO | disclosed |
| WO-2023282315-A1 | METHOD FOR SECRETORY PRODUCTION OF UNNATURAL-AMINO-ACID-CONTAINING PROTEIN | 味の素株式会社 | 2023-01-12 | — | — | WO | disclosed |
| EP-3287523-B1 | METHOD FOR SECRETORY PRODUCTION OF PROTEIN | AJINOMOTO KK (JP) | 2022-06-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260071227-A1 | METHOD FOR SECRETORY PRODUCTION OF PROTEINS | MDH1, MDH2, MLYCD | CALCRL 2459/4885SLC6A2 3411/4885BACE1 4149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.